Part of our responsibility as a global pharmaceutical company is to ensure the safety of the patients who use our products. At Hikma, we are committed to medicine safety in all cases where the medicine is prescribed to patients.
Through our robust commitment to pharmacovigilance, we ensure we remain focused on patients' safety. Our Medical Affairs department manages a pharmacovigilance system for the collection, collation, and evaluation of adverse drug reactions and the implementation of effective corrective and preventive actions.
For further information or to report adverse reactions please contact email@example.com.
United States Consumer Product Safety Improvement Act of 2008
Set out below are the Certificate of Compliance and related Product List by NDC in relation to the compliance by West-Ward Pharmaceutical Corp., with the United States Consumer Product Safety Improvement Act of 2008.
For additional information, please contact one of the following: